Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析

◆英語タイトル:Ego Pharmaceuticals Pty Ltd - Strategic SWOT Analysis Review
◆商品コード:DATA904C15520
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:23
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:オーストラリア
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD125 ⇒換算¥18,500見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD375 ⇒換算¥55,500見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Ego Pharmaceuticals Pty Ltd – Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services.
This up-to-the-minute company report will help you to formulate strategies to drive your business by enabling you to understand your partners, customers and competitors better.

Scope

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – GlobalData’s summarization of the company’s business strategy.
- SWOT analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list of key locations and subsidiaries of the company, including contact details.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.

Highlights

Ego Pharmaceuticals Pty Ltd (EPP) is a pharmaceutical company that develops, manufactures and markets skin and health care products. Its product portfolio includes hand sanitizers, medicated lotions, hair shampoos and conditioners, moisturizing and anti-ageing creams, skin whitening creams, deodorants and heat powders, among others. EPP offers products for the treatment of skin conditions such as acne, ageing of skin, sensitive skin and scalp, bed sore prevention, atopic eczema, itching, pimples, rough heels, lip care, chicken pox, dry skin, dermatitis and dandruff, among others. The company has presence in the Middle East and Asia Pacific. EPP is headquartered in Braeside, Victoria, Australia.

Ego Pharmaceuticals Pty Ltd Key Recent Developments

Feb 22,2018 Australian Exporter of the year continues local investment with $35M global headquarters opened in Melbourne by Minister Hunt

Reasons to Buy

- Gain key insights into the company for academic or business research purposes. Key elements such as SWOT analysis and corporate strategy are incorporated in the profile to assist your academic or business research needs.
- Identify potential customers and suppliers with this report’s analysis of the company’s business structure, operations, major products and services and business strategy.
- Understand and respond to your competitors’ business structure and strategies with GlobalData’s detailed SWOT analysis. In this, the company’s core strengths, weaknesses, opportunities and threats are analyzed, providing you with an up to date objective view of the company.
- Examine potential investment and acquisition targets with this report’s detailed insight into the company’s strategic, business and operational performance.

Note: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents
List of Tables
Section 1 – About the Company
Ego Pharmaceuticals Pty Ltd – Key Facts
Ego Pharmaceuticals Pty Ltd – Key Employees
Ego Pharmaceuticals Pty Ltd – Key Operational Employees
Ego Pharmaceuticals Pty Ltd – Major Products and Services
Ego Pharmaceuticals Pty Ltd – History
Ego Pharmaceuticals Pty Ltd – Company Statement
Ego Pharmaceuticals Pty Ltd – Locations And Subsidiaries
Head Office
Other Locations & Subsidiaries
Section 2 – Company Analysis
Company Overview
Ego Pharmaceuticals Pty Ltd – Business Description
Ego Pharmaceuticals Pty Ltd – SWOT Analysis
SWOT Analysis – Overview
Ego Pharmaceuticals Pty Ltd – Strengths
Ego Pharmaceuticals Pty Ltd – Weaknesses
Ego Pharmaceuticals Pty Ltd – Opportunities
Ego Pharmaceuticals Pty Ltd – Threats
Ego Pharmaceuticals Pty Ltd – Key Competitors
Section 3 – Company’s Recent Developments
Feb 22, 2018: Australian Exporter of the year continues local investment with $35M global headquarters opened in Melbourne by Minister Hunt
Section 4 – Appendix
Methodology
About GlobalData
Contact Us
Disclaimer

List of Tables
Ego Pharmaceuticals Pty Ltd, Key Facts
Ego Pharmaceuticals Pty Ltd, Key Employees
Ego Pharmaceuticals Pty Ltd, Key Operational Employees
Ego Pharmaceuticals Pty Ltd, Major Products and Services
Ego Pharmaceuticals Pty Ltd, History
Ego Pharmaceuticals Pty Ltd, Subsidiaries
Ego Pharmaceuticals Pty Ltd, Key Competitors

★海外企業調査レポート[Ego Pharmaceuticals Pty Ltd:企業の戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Anworth Mortgage Asset Corp (ANH):企業の財務・戦略的SWOT分析
    Summary Anworth Mortgage Asset Corp (Anworth) is a financial service provider that provides mortgage real estate investment services. The company invests in mortgage-backed securities on a leveraged basis. It operates through agency credit-backed securities and non-agency credit-backed securities. A …
  • Applied Materials Inc (AMAT):企業の財務・戦略的SWOT分析
    Applied Materials Inc (AMAT) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Petrochemical Industries Co:企業の戦略的SWOT分析
    Petrochemical Industries Co - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major product …
  • SciGen Ltd (SIE):製薬・医療:M&Aディール及び事業提携情報
    Summary SciGen Ltd (SciGen), a subsidiary of Bioton SA is a biotechnology company that manufactures, develops, and markets recombinant human health care biotechnology derived products. The company’s products include second generation recombinant human insulin, recombinant human growth hormone and si …
  • Iamgold Corporation:企業のM&A・事業提携・投資動向
    Iamgold Corporation - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Iamgold Corporation Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), …
  • Royale Energy Inc (ROYL):石油・ガス:M&Aディール及び事業提携情報
    Summary Royale Energy Inc (Royale Energy) is an independent exploration and production company. The company undertakes the business of acquisition, development, and marketing of oil and natural gas properties. Its business activities comprise acquisition of oil and gas interests and proved reserves, …
  • Kiwibank Limited:企業の戦略・SWOT・財務情報
    Kiwibank Limited - Strategy, SWOT and Corporate Finance Report Summary Kiwibank Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • China CITIC Bank Corporation Limited:企業の戦略・SWOT・財務情報
    China CITIC Bank Corporation Limited - Strategy, SWOT and Corporate Finance Report Summary China CITIC Bank Corporation Limited - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysi …
  • Dar Al Dawa Development & Investment Co Ltd (DADI):企業の財務・戦略的SWOT分析
    Dar Al Dawa Development & Investment Co Ltd (DADI) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key …
  • Yungjin Pharm Co Ltd (003520):企業の財務・戦略的SWOT分析
    Summary Yungjin Pharm Co Ltd (Yungjin), a subsidiary of KT&G Corp is a pharmaceutical company that develops, manufactures and distributes active pharmaceutical ingredients, formulations and tonic drinks. The company provides API products such as cephalosporins and other general products. It also off …
  • Mentor Graphics Corporation:企業の戦略・SWOT・財務分析
    Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report Summary Mentor Graphics Corporation - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and ser …
  • Abraxas Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis – Q4, 2017
    Abraxas Petroleum Corp Oil & Gas Exploration and Production Operations and Cost Analysis - Q4, 2017 Summary Abraxas Petroleum Corp (Abraxas) is an oil and gas company. The company offers exploration, production and development of oil and gas properties across the US. Its properties are located in Mi …
  • Ethiopian Electric Power Corp:電力:M&Aディール及び事業提携情報
    Summary Ethiopian Electric Power Corp (Ethiopian Electric Power), formerly The Ethiopian Electric Light and Power Authority, is an electric utility that generates, transmits and distributes electricity. The utility maintains the Interconnected System and transmits electricity from hydropower plants …
  • Eiger BioPharmaceuticals Inc (EIGR):企業の財務・戦略的SWOT分析
    Summary Eiger BioPharmaceuticals Inc (Eiger) formerly Celladon Corp, is a clinical-stage biopharmaceutical company that focuses on the development and commercialization of novel drugs for the treatment of orphan diseases. The company provides pipeline products such as Lonafarnib and Lambda, which ar …
  • PolyNovo Ltd (PNV):医療機器:M&Aディール及び事業提携情報
    Summary PolyNovo Ltd (PolyNovo), formerly Calzada Ltd, is a medical device company that develops, manufactures and commercializes biodegradable polymers for use in medical devices. The company provides products such as biodegradable temporizing matrix and negative pressure wound therapy dressing sys …
  • Commercial Metals Co:企業の戦略・SWOT・財務分析
    Commercial Metals Co - Strategy, SWOT and Corporate Finance Report Summary Commercial Metals Co - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings …
  • Digna Biotech SL-製薬・医療分野:企業M&A・提携分析
    Summary Digna Biotech SL (Digna) is a biotechnology company that specializes in the development and commercialization of robust clinical therapeutic candidates. The company’s pipeline portfolio includes cutaneous manifestation of scleroderma, clinical indications for kidney transplant and liver surg …
  • Aurora Diagnostics LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Aurora Diagnostics LLC (Aurora Diagnostics) is a healthcare service provider that offers hospital and pathology services. The center’s pathology services include gastrointestinal pathology services, heamato-pathology services, dermatology services, urologic pathology, pathology consultation, …
  • BioElectron Technology Corp-製薬・医療分野:企業M&A・提携分析
    Summary BioElectron Technology Corp(BioElectron) formerly known as Edison Pharmaceuticals Inc, discovers and develops shared (redox) disease drugs. The company’s pipeline products comprise EPI-743, a drug candidate for inherited mitochondrial diseases and EPI-589 drug candidate entering phase 1 clin …
  • ZAPPALLAS, Inc. (3770):企業の財務・戦略的SWOT分析
    ZAPPALLAS, Inc. (3770) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses an …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆